Evidence map›Paper›PMID 23312339›Full record

ArticleDrug and alcohol dependence2013

Circumstances of initiation into new-type drug use among adults in Shanghai: are there differences by types of first new-type drug used?

Yingying Ding, Na He, Roger Detels

Open access · greenAbstract readComparative Study
In one paragraph

Article in Drug and alcohol dependence, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Yingying DingDepartment of Epidemiology, School of Public Health, Fudan University, and the Key Laboratory of Public Health Safety of Ministry of Education, Shanghai, China.
Na He
Roger Detels
UCLA Health · USFudan University · CN

Funding

UCLA Rapid, Relevant, Rigorous Implementation Science HubP30MH058107 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI RAPHAEL J LANDOVITZ · 1997 to 2026
$53.5M
UCLA Fogarty AITRP-Supplement for North IndiaD43TW000013 · FIC · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DETELS, ROGER · 1988 to 2012
$14.6M
FIC NIH HHS D43 TW000013NIMH NIH HHS P30 MH058107
6 · The paper itself

Abstract

backgroundThis study investigated circumstances of initiating new-type drug use among adult new-type drug users and differences among those who first used methamphetamine, ecstasy and ketamine.

methodsA total of 276 participants were recruited, using respondent-driven sampling (RDS) from nine seeds recruited through NGOs, social workers and outreach workers in Shanghai, China.

resultsMethamphetamine was the most frequently reported first new-type drug used (37.1%), followed by ecstasy (35.6%) and ketamine (20.0%). 38.7% of participants initiated new-type drug use before the age of 21 years. 47.8% knew at initiation that club drugs can be harmful. Most were introduced to new-type drug use by friends, spouses or boy/girlfriends. The three most common reasons for initiation were curiosity, peer influence, and wishing to dull one's emotions. Those first using methamphetamine were more likely to be female, have a monthly individual income less than 3000 Yuan (approx. $476), initiate use at 21 years or older and at private setting than those first using ecstasy and ketamine.

conclusionsThere is an urgent need for drug education efforts in China to raise awareness of the harms of new-type drugs, as well as to increase knowledge about the paradox of new-type drug effects. Drug prevention and intervention programs should be tailore to target populations and their social context.

Indexed as

Illicit DrugsKetamineMethamphetamineN-Methyl-3,4-methylenedioxyamphetamineAdolescentAdultChinaDrug UsersFemaleHumansMaleMiddle AgedSubstance-Related DisordersYoung AdultIllicit DrugsKetamineMethamphetamineN-Methyl-3,4-methylenedioxyamphetamineChinaEcstasyInitiationKetamineMethamphetamineNew-type drugs

Identifiers

PMID23312339
PMCPMC3644522
OpenAlexW2119801218

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.